Publication Name	World Journal of Pharmacology
Manuscript ID	4362
Country	Austria

Received	2013-06-28 10:51
Peer-Review Started	2013-06-28 16:50
To Make the First Decision	2013-08-08 11:11
Return for Revision	2013-08-19 20:14
Revised	2013-08-21 22:14
Second Decision	2013-10-16 11:16
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-10-16 12:08
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-10-25 15:59
Publish the Manuscript Online	2013-12-18 16:32

ISSN	2220-3192 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Pharmacology & Pharmacy
Manuscript Type	Minireviews
Article Title	Statins role in cancer prevention and development-recent meta-analyses
Manuscript Source	Invited Manuscript
All Author List	Martin Künzl, Christine Wasinger and Martin Hohenegger
Funding Agency and Grant Number	Funding Agency Grant Number Herzfeldersche Familienstiftung and the Austrian Science foundation P22385
Corresponding Author	Martin Hohenegger, MD, Associate Professor, Medical University of Vienna, Center for Physiology and Pharmacology, Institute of Pharmacology, Währingerstrasse 13A, A-1090 Vienna, Austria. martin.hohenegger@meduniwien.ac.at
Key Words	3-Hydroxy-3-methylglutaryl-coenzyme A-reductase inhibitors; Low density lipoprotein cholesterol; Cancer; Breast cancer; Apoptosis; Statins
Core Tip	The 3-hydroxy-3 methyl CoA (HMG-CoA) reductase inhibitors, the statins are one of the most frequently prescribed drugs in industrialized countries. Statins are well tolerated cholesterol lowering drugs which significantly help to reduce cardiovascular events. Clinical trials and meta-analyzes thereof now accumulate evidence that development of cancer might be reduced in some tissues. In this review the current status of evidence for an anti-cancer effect of statins will be critically evaluated. In particular, colon and prostate cancer are assessed in greater detail.
Publish Date	2013-12-18 16:32
Citation	Künzl M, Wasinger C, Hohenegger M. Statins role in cancer prevention and development-recent meta-analyses. World J Pharmacol 2013; 2(4): 100-106
URL	http://www.wjgnet.com/2220-3192/full/v2/i4/100.htm
DOI	http://dx.doi.org/10.5497/wjp.v2.i4.100

Full Article (PDF)	WJP-2-100.pdf
Full Article (Word)	WJP-2-100.doc
Manuscript File	4362-Review.doc
Answering Reviewers	4362-Answering reviewers.PDF
Copyright License Agreement	4362-Copyright assignment.PDF
Peer-review Report	4362-Peer reviewer(s).pdf
Scientific Editor Work List	4362-Scientific editor work list.doc